Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis-A Registry Project
NCT02456363Phase 2Unknown
- Sponsor
- Chung Shan Medical University
- Start
- Nov 2009
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in ankylosing spondylitis (AS) (4 arms), sponsored by Chung Shan Medical University. Primary endpoint: Modified Stoke Ankylosing Spondylitis Spinal Score at 92 weeks. Status: unknown.
02
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02456363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456363.